202 related articles for article (PubMed ID: 30223539)
1. The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review.
Greenaway C; Makarenko I; Chakra CNA; Alabdulkarim B; Christensen R; Palayew A; Tran A; Staub L; Pareek M; Meerpohl JJ; Noori T; Veldhuijzen I; Pottie K; Castelli F; Morton RL
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223539
[TBL] [Abstract][Full Text] [Related]
2. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review.
Myran DT; Morton R; Biggs BA; Veldhuijzen I; Castelli F; Tran A; Staub LP; Agbata E; Rahman P; Pareek M; Noori T; Pottie K
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200406
[TBL] [Abstract][Full Text] [Related]
3. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; Noori T; van der Werf MJ; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637888
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review.
Pottie K; Lotfi T; Kilzar L; Howeiss P; Rizk N; Akl EA; Dias S; Biggs BA; Christensen R; Rahman P; Magwood O; Tran A; Rowbotham N; Pharris A; Noori T; Pareek M; Morton R
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30096905
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy.
Coppola N; Alessio L; De Pascalis S; Macera M; Di Caprio G; Messina V; Onorato L; Minichini C; Stanzione M; Stornaiuolo G; Starace M; Monari C; Calò F; Sagnelli C; Pisaturo M
Infect Dis Poverty; 2024 May; 13(1):39. PubMed ID: 38802954
[TBL] [Abstract][Full Text] [Related]
8. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
[No Abstract] [Full Text] [Related]
9. Securing sustainable funding for viral hepatitis elimination plans.
Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
Kim KA; Chung W; Choi HY; Ki M; Jang ES; Jeong SH
Liver Int; 2019 Jan; 39(1):60-69. PubMed ID: 29998565
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review.
Agbata EN; Morton RL; Bisoffi Z; Bottieau E; Greenaway C; Biggs BA; Montero N; Tran A; Rowbotham N; Arevalo-Rodriguez I; Myran DT; Noori T; Alonso-Coello P; Pottie K; Requena-Méndez A
Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30577567
[TBL] [Abstract][Full Text] [Related]
12. Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review.
Hui C; Dunn J; Morton R; Staub LP; Tran A; Hargreaves S; Greenaway C; Biggs BA; Christensen R; Pottie K
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30241320
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
European Union HCV Collaborators
Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
[TBL] [Abstract][Full Text] [Related]
14. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.
Cortesi PA; Barca R; Giudicatti G; Mossini S; Ciaccio A; Iannazzo S; Micale M; Cesana G; Mantovani LG
Aliment Pharmacol Ther; 2019 May; 49(9):1126-1133. PubMed ID: 30843268
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region.
Moonen CPB; den Heijer CDJ; Dukers-Muijrers NHTM; van Dreumel R; Steins SCJ; Hoebe CJPA
Front Public Health; 2023; 11():1118227. PubMed ID: 36875381
[TBL] [Abstract][Full Text] [Related]
16. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS
Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
[TBL] [Abstract][Full Text] [Related]
18. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study.
Singer AW; Reddy KR; Telep LE; Osinusi AO; Brainard DM; Buti M; Chokkalingam AP
Aliment Pharmacol Ther; 2018 May; 47(9):1278-1287. PubMed ID: 29516535
[TBL] [Abstract][Full Text] [Related]
19. The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands.
Al Khayat MNMT; Eijsink JFH; Postma MJ; Wilschut JC; van Hulst M
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32825680
[TBL] [Abstract][Full Text] [Related]
20. Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA.
Deblonde J; Sasse A; Del Amo J; Burns F; Delpech V; Cowan S; Levoy M; Keith L; Pharris A; Amato-Gauci A; Noori T
BMC Public Health; 2015 Dec; 15():1228. PubMed ID: 26654427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
